Middle East And Africa Drug Device Combination Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East And Africa Drug Device Combination Market Analysis

  • Healthcare
  • Published Report
  • Sep 2021
  • MEA
  • 350 Pages
  • No of Tables: 40
  • No of Figures: 46

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PATENT ANALYSIS

4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS

4.1.2 APPROVAL BY AGENCY

4.1.3 PATENT GRANT

4.1.4 PATENT CERTIFICATIONS:

5 PIPELINE ANALYSIS

6 REGULATORY FRAMEWORKS:

6.1 U.S.

6.2 EUROPE

6.3 CANADA

6.4 AUSTRALIA

6.5 JAPAN

6.6 CHINA

6.7 SOUTH KOREA

7 REGIONAL SUMMARY

7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET

7.1.1 OVERVIEW

7.2 EUROPE DRUG-DEVICE COMBINATION MARKET

7.2.1 OVERVIEW

7.3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET

7.3.1 OVERVIEW

7.4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET

7.4.1 OVERVIEW

7.5 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET

7.5.1 OVERVIEW

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

8.1.2 GROWING GERIATRIC POPULATION

8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES

8.1.4 RISING RATES OF OBESITY

8.2 RESTRAINTS

8.2.1 PRODUCT RECALLS

8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS

8.3 OPPORTUNITIES

8.3.1 RISING EXPENDITURE ON HEALTHCARE

8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES

8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES

8.4 CHALLENGE

8.4.1 STRICT REGULATORY FRAMEWORK

9 IMPACT OF COVID-19 PANDEMIC ON THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET

9.1 IMPACT ON PRICE

9.2 IMPACT ON SUPPLY CHAIN

9.3 IMPACT ON DEMAND

9.4 STRATEGIC DECISIONS FOR MANUFACTURERS

9.5 CONCLUSION

10 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT

10.1 OVERVIEW

10.2 AUTO-INJECTOR

10.2.1 WEARABLE AUTO-INJECTOR

10.2.2 HAND HELD AUTO-INJECTOR

10.3 MICRONEEDLE PATCH

10.4 DIGITAL PILL

10.5 SMART INHALER

10.6 DRUG DELIVERY HYDROGELS

10.7 DRUG-ELUTING LENS

10.8 OTHERS

11 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 ORTHOPEDIC DISEASES

11.3 RESPIRATORY DISEASES

11.4 DIABETES

11.5 ONCOLOGY

11.6 CARDIOVASCULAR DISEASES

11.7 OTHERS

12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER

12.1 OVERVIEW

12.2 CLINICS

12.3 HOSPITALS

12.4 HOME CARE SETTINGS

12.5 AMBULATORY CARE CENTERS

12.6 OTHERS

13 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAILS SALES

13.4 OTHERS

14 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY REGION

14.1 MIDDLE EAST AND AFRICA

14.1.1 SOUTH AFRICA

14.1.2 REST OF MIDDLE EAST AND AFRICA

15 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENT

17.2 AMGEN INC.

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENTS

17.3 GLAXOSMITHKLINE PLC

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENT

17.4 BD

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENTS

17.5 MEDTRONIC

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENTS

17.6 BAYER AG

17.6.1 COMPANY SNAPSHOT

17.6.2 REVENUE ANALYSIS

17.6.3 PRODUCT PORTFOLIO

17.6.4 RECENT DEVELOPMENT

17.7 CGBIO

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENTS

17.8 COSMED PHARMACEUTICAL CO.LTD.

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENTS

17.9 E3D ELCAM DRUG DELIVERY DEVICES

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 EITAN MEDICAL

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENTS

17.11 EOFLOW CO., LTD.

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENTS

17.12 FINDAIR SP. Z O. O.

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

17.13 INSULET CORPORATION

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 MEDIPRINT

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENT

17.15 METP PHARMA AG

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENT

17.16 MICRON BIOMEDICAL, INC.

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENTS

17.17 NANOPASS

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENT

17.18 OCUMEDIC

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENT

17.19 OTSUKA AMERICA PHARMACEUTICAL, INC.

17.19.1 COMPANY SNAPSHOT

17.19.2 REVENUE ANALYSIS

17.19.3 PRODUCT PORTFOLIO

17.19.4 RECENT DEVELOPMENT

17.2 PROPELLER HEALTH

17.20.1 COMPANY SNAPSHOT

17.20.2 REVENUE ANALYSIS

17.20.3 PRODUCT PORTFOLIO

17.20.4 RECENT DEVELOPMENT

17.21 RAPHAS CO., LTD.

17.21.1 COMPANY SNAPSHOT

17.21.2 REVENUE ANALYSIS

17.21.3 PRODUCT PORTFOLIO

17.21.4 RECENT DEVELOPMENT

17.22 SENSIRION AG SWITZERLAND

17.22.1 COMPANY SNAPSHOT

17.22.2 REVENUE ANALYSIS

17.22.3 PRODUCT PORTFOLIO

17.22.4 RECENT DEVELOPMENT

17.23 . SONCEBOZ

17.23.1 COMPANY SNAPSHOT

17.23.2 PRODUCT PORTFOLIO

17.23.3 RECENT DEVELOPMENT

17.24 SUBCUJECT APS

17.24.1 COMPANY SNAPSHOT

17.24.2 PRODUCT PORTFOLIO

17.24.3 RECENT DEVELOPMENT

17.25 THERAJECT

17.25.1 COMPANY SNAPSHOT

17.25.2 PRODUCT PORTFOLIO

17.25.3 RECENT DEVELOPMENT

17.26 VAXESS TECHNOLOGIES INC.

17.26.1 COMPANY SNAPSHOT

17.26.2 PRODUCT PORTFOLIO

17.26.3 RECENT DEVELOPMENTS

17.27 VAXXAS

17.27.1 COMPANY SNAPSHOT

17.27.2 PRODUCT PORTFOLIO

17.27.3 RECENT DEVELOPMENTS

17.28 YPSOMED

17.28.1 COMPANY SNAPSHOT

17.28.2 REVENUE ANALYSIS

17.28.3 PRODUCT PORTFOLIO

17.28.4 RECENT DEVELOPMENTS

17.29 ZIMMER BIOMET

17.29.1 COMPANY SNAPSHOT

17.29.2 REVENUE ANALYSIS

17.29.3 PRODUCT PORTFOLIO

17.29.4 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST AND AFRICA DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS

TABLE 2 MOST OBESE COUNTRIES OF ASIA-PACIFIC 2020

TABLE 3 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA MICRONEEDLE PATCH IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA DIGITAL PILL IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA SMART INHALER IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA DRUG DELIVERY HYDROGELS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA DRUG-ELUTING LENS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA ORTHOPEDIC DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA RESPIRATORY DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA DIABETES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA ONCOLOGY IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CLINICS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA HOSPITALS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA HOME CARE SETTINGS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA DIRECT TENDER IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA RETAIL SALES IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 35 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 36 SOUTH AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 37 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 38 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 39 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 REST OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE

FIGURE 8 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID

FIGURE 10 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION

FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028

FIGURE 15 PORTER'S 5 FORCES

FIGURE 16 PESTEL'S MODEL

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET

FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.

FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE

FIGURE 20 AGEING POPULATION IN THE WORLD (IN MILLIONS)

FIGURE 21 NORTH AMERICA AGEING POPULATION (IN MILLION)

FIGURE 22 EUROPE AGEING POPULATION (IN MILLION)

FIGURE 23 ASIA-PACIFIC AGEING POPULATION (IN MILLION)

FIGURE 24 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016

FIGURE 25 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020

FIGURE 26 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)

FIGURE 27 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)

FIGURE 28 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 29 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020

FIGURE 30 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 31 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 32 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 33 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020

FIGURE 34 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2021-2028 (USD MILLION)

FIGURE 35 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)

FIGURE 36 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 37 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 38 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 39 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 40 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 41 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)

FIGURE 42 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)

FIGURE 43 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 44 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 45 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)

FIGURE 46 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)

Frequently Asked Questions

The Middle East and Africa Drug-Device Combination Market size will be worth USD 1,274.40 million by 2028.
The Middle East and Africa Drug-Device Combination Market growth rate will be 8.7% by 2028.
The Increasing demand for medical devices and rising government initiatives are the growth drivers of the Middle East and Africa Drug-Device Combination Marke.
The product, application, end user, and distribution channel are the factors on which the Middle East and Africa Drug-Device Combination Market research is based.
The major companies in the Middle East and Africa Drug-Device Combination Market are Medtronic, Amgen Inc., B.D., Eitan Medical, E3D Elcam Drug Delivery Devices, GlaxoSmithKline plc, Bayer AG, NanoPass, Janssen Pharmaceuticals, Inc.(a subsidiary of Johnson & Johnson Sevices, Inc.), Otsuka America Pharmaceutical, Inc.